Timing of response to venetoclax combination treatment in older patients with acute myeloid leukaemia

ASCO 2020: Latest developments in EGFR-mutated non-small cell lung cancer

Venetoclax with bortezomib and dexamethasone in relapsed/refractory multiple myeloma

KRd vs VRd for initial therapy of newly diagnosed multiple myeloma

Association of BRCA alterations with response to PARP inhibitors in metastatic castration-resistant prostate cancer

LuPSMA vs cabazitaxel in metastatic castration-resistant prostate cancer progressing after docetaxel

The paediatric precision oncology study INFORM: Clinical outcome and benefit for molecular subgroups

Brigatinib for NSCLC, latest research and overcoming complications

Sym015 shows superior specificity compared to TKIs for NSCLC

Cisplatin plus/minus veliparib in metastatic TNBC and/or germline BRCA-associated breast cancer

Better genetic diagnostics in Ugandan breast cancer patients

ADAURA results: Adjuvant osimertinib for EGFRm non-small cell lung cancer